The data supporting this EUA for baricitinib combi
Post# of 148167
(Total Views: 919)
Posted On: 11/20/2020 1:30:25 AM
Quote:
The data supporting this EUA for baricitinib combined with remdesivir are based on a randomized, double-blind, placebo-controlled clinical trial (ACTT-2), which was conducted by the National Institute of Allergy and Infectious Diseases (NIAID).
Another Fauci special
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼